Suppr超能文献

卡维地洛可减轻心肺复苏期间肾上腺素的不良反应。

Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation.

作者信息

Huang Lei, Weil Max Harry, Sun Shijie, Tang Wanchun, Fang Xiangshao

机构信息

The Institute of Critical Care Medicine, Palm Springs, CA, USA.

出版信息

J Cardiovasc Pharmacol Ther. 2005 Jun;10(2):113-20. doi: 10.1177/107424840501000205.

Abstract

INTRODUCTION

Earlier studies have implicated the adverse effects of beta- and alpha(1)-adrenergic receptors during cardiopulmonary resuscitation (CPR). Because carvedilol is both a nonselective beta- and alpha1-selective adrenergic receptor-blocking agent, we hypothesized that pretreatment with carvedilol would convert the actions of epinephrine to that of a selective alpha2-agonist.

METHODS

Ventricular fibrillation (VF) was induced in Sprague-Dawley rats weighing approximately 500 g. Animals were randomized to 4 groups of 5 animals each: (1) placebo pretreatment and epinephrine treatment, (2) carvedilol pretreatment and placebo treatment, (3) carvedilol pretreatment and epinephrine treatment, and (4) placebo pretreatment and placebo treatment. Carvedilol (50 microg/kg) was injected as a bolus into the right atrium 15 minutes before VF was induced. VF was untreated for 8 minutes, after which CPR (chest compression and mechanical ventilation) was begun. Epinephrine (30 microg/kg) was injected into the right atrium 2 minutes after the start of CPR. Electrical defibrillation was attempted after 14 minutes of VF.

RESULTS

All but 2 animals were successfully resuscitated. Approximately equivalent increases in coronary perfusion pressure from 23 +/- 1 mm Hg to 30 +/- 3 mm Hg were observed after the injection of epinephrine independently of carvedilol pretreatment. Carvedilol pretreatment followed by epinephrine treatment reduced early postresuscitation ventricular ectopy (116 +/- 147 vs 834 +/- 380, P < .01) and minimized increases in arterial blood lactate at 5 minutes after resuscitation (10.9 +/- 2.1 mmol/L vs 17.4 +/- 3.5 mmol/L, P < .01). The postresuscitation cardiac index measured 4 hours later was increased (307 +/- 43 mL x min(-1) x kg(-1) vs 210 +/- 6 mL x min(-1) x kg(-1), P < .05). Left ventricular diastolic pressures were decreased (6 +/- 1 vs 14 +/- 1 mm Hg, P < .05). Animals pretreated with carvedilol survived longer (71 +/- 1 vs 45 +/- 22 hours, P < .05) and with less postresuscitation neurologic deficit.

CONCLUSION

After beta- and alpha1-adrenergic blockade with carvedilol before inducing cardiac arrest, epinephrine administered during CPR yielded better postresuscitation myocardial and neurologic functions and significantly increased postresuscitation survival.

摘要

引言

早期研究表明,β-肾上腺素能受体和α1-肾上腺素能受体在心肺复苏(CPR)过程中具有不良影响。由于卡维地洛是一种非选择性β-肾上腺素能受体阻滞剂和α1-选择性肾上腺素能受体阻滞剂,我们推测,卡维地洛预处理可将肾上腺素的作用转变为选择性α2-激动剂的作用。

方法

在体重约500 g的Sprague-Dawley大鼠中诱导室颤(VF)。将动物随机分为4组,每组5只:(1)安慰剂预处理加肾上腺素治疗;(2)卡维地洛预处理加安慰剂治疗;(3)卡维地洛预处理加肾上腺素治疗;(4)安慰剂预处理加安慰剂治疗。在诱导VF前15分钟,将卡维地洛(50μg/kg)作为推注剂注入右心房。VF持续8分钟不予处理,之后开始进行CPR(胸外按压和机械通气)。在CPR开始2分钟后,将肾上腺素(30μg/kg)注入右心房。VF持续14分钟后尝试进行电除颤。

结果

除2只动物外,其余均成功复苏。注射肾上腺素后,无论是否进行卡维地洛预处理,冠状动脉灌注压均有近似的升高,从23±1 mmHg升至30±3 mmHg。卡维地洛预处理后再给予肾上腺素治疗,可减少复苏后早期的室性异位搏动(116±147次 vs 834±380次,P<.01),并使复苏后5分钟时动脉血乳酸水平的升高最小化(10.9±2.1 mmol/L vs 17.4±3.5 mmol/L,P<.01)。复苏4小时后测量的复苏后心脏指数升高(307±43 mL·min-1·kg-1 vs 210±6 mL·min-1·kg-1,P<.05)。左心室舒张压降低(6±1 mmHg vs 14±1 mmHg,P<.05)。经卡维地洛预处理的动物存活时间更长(71±1小时 vs 45±22小时,P<.05),且复苏后神经功能缺损较少。

结论

在诱导心脏骤停前用卡维地洛进行β-和α1-肾上腺素能受体阻滞,CPR期间给予肾上腺素可使复苏后心肌和神经功能更好,并显著提高复苏后的生存率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验